Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

OHRP - Ohr Pharmaceutical Inc.

Previous close
5.39
5.390   100.000%

Share volume: 0
Last Updated: Fri 12 Jul 2019 10:00:00 PM CEST
Biotechnology: -0.86%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
30%
Profitability 25%
Dept financing 3%
Liquidity 20%
Performance 45%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$5.39
P/E Ratio 
N/A
DAY RANGE
$5.39 - $5.39
EPS 
-$3.17
52 WEEK RANGE
$1.58 - $6.28
52 WEEK CHANGE
$29.26
MARKET CAP 
15.248 M
YIELD 
N/A
SHARES OUTSTANDING 
2.829 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$2,703,944
AVERAGE 10 VOLUME 
$411,253
AVERAGE 30 VOLUME 
$175,502
Company detail
CEO:
Region: US
Website: http://www.ohrpharmaceutical.com
Employees: 3
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY.

Recent news